Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term 0 (Isoenzymes). Found 4 abstracts

Gate L, Majumdar RS, Lunk A, Tew KD. Influence of glutathione S-transferase pi and p53 expression on tumor frequency and spectrum in mice. International journal of cancer. 2005 Jan;113(1):29-35.
Badawi AF, Eldeen MB, Liu Y, Ross EA, Badr MZ. Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma. Cancer Research. 2004 Feb;64(3):1181-9.
Badawi AF, Liu Y, Eldeen MB, Morrow W, Razak ZR, Maradeo M, Badr MZ. Age-associated changes in the expression pattern of cyclooxygenase-2 and related apoptotic markers in the cancer susceptible region of rat prostate. Carcinogenesis. 2004 Sep;25(9):1681-8.
Findlay VJ, Townsend DM, Saavedra JE, Buzard GS, Citro ML, Keefer LK, Ji X, Tew KD. Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrug. Molecular Pharmacology. 2004 May;65(5):1070-9.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term 0 (Isoenzymes)

me [Metabolism] Isoenzymes 0 (Isoenzymes) EC 2-5-1-18 (glutathione S-transferase pi) aa [Analogs & Derivatives] Apoptosis Mice pd [Pharmacology] EC 2-5-1-18 (Glutathione Transferase) en [Enzymology] Enzymologic Gene Expression Regulation de [Drug Effects] 363-24-6 (Dinoprostone) Prostaglandin-Endoperoxide Synthase ge [Genetics] Cell Division Dinoprostone Rats Glutathione Transferase EC 1-14-99-1 (Prostaglandin-Endoperoxide Synthase) Transcription Factors Experimental Neoplasms Aging Carcinogens Piperazines 35661-60-0 (N-(fluorenyl-9-methoxycarbonyl)leucine) Experimental Mammary Neoplasms 0 (Sulfonamides) 41598-07-6 (Prostaglandin D2) Cytoplasmic and Nuclear Receptors 0 (Fluorenes) Messenger) 0 (RNA ai [Antagonists & Inhibitors] Methylnitrosourea bi [Biosynthesis] Proto-Oncogene Proteins c-bcl-2 0 (15-deoxyprostaglandin J2) Messenger RNA Time Factors 0 (Anticarcinogenic Agents) pa [Pathology] Sprague-Dawley Rats Multidrug Resistance-Associated Proteins Azo Compounds Mitogen-Activated Protein Kinases Prostate 0 (Azo Compounds) 3T3 Cells Leukotriene C4 0 (Cyclooxygenase Inhibitors) 10102-43-9 (Nitric Oxide) Prodrugs EC 1-14-99 (cyclooxygenase 2) 4-dinitro-5-(N-methyl-N-4-carboxyphenylamino)phenyl 0 (O(2)-(2 Drug Synergism N-dimethylamino)diazen-1-ium-1 1-N-2-diolate) Prostaglandin D2 Neoplastic Gene Expression Regulation US Gov't Support-PHS Male 0 (Multidrug Resistance-Associated Proteins) ci [Chemically Induced] Sulfonamides 0 (Transcription Factors) Female 0 (Prodrugs) ad [Administration & Dosage] Immunoblotting US Gov't Support-Non-PHS 0 (Piperazines) Cultured Tumor Cells EC 2-7-1-37 (Mitogen-Activated Protein Kinases) EC 2-7-1-37 (JNK Mitogen-Activated Protein Kinases) 0 (Bax protein) EC 2-7-1-37 (Protein Kinase C) ch [Chemistry] 61-90-5 (Leucine) 0 (Proto-Oncogene Proteins c-bcl-2) Biological) 0 (Tumor Markers Knockout Mice pc [Prevention & Control] SCID Mice Proto-Oncogene Proteins EC 2-7-1-37 (p38 Mitogen-Activated Protein Kinases) 0 (Nitric Oxide Donors) Cell Cycle cs [Chemical Synthesis] Biological Markers Anticarcinogenic Agents 72025-60-6 (Leukotriene C4) Enzyme Activation Cytoplasmic and Nuclear) 0 (Receptors 0 (Carcinogens) 0 (Biological Markers) ag [Agonists] Fluorenes 4-Aminobenzoic Acid 0 (Proto-Oncogene Proteins) Protein Kinase C 169590-42-5 (celecoxib) Protein p53 Nitric Oxide Donors 684-93-5 (Methylnitrosourea) Genotype p38 Mitogen-Activated Protein Kinases df [Deficiency] Biological Tumor Markers 2-diolate) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1 0 (Protein p53) Disease Susceptibility JNK Mitogen-Activated Protein Kinases Cyclooxygenase Inhibitors Inbred F344 Rats Nitric Oxide 4-dinitrophenyl) 0 (O(2)-(2 EC 1-14-99-1 (cyclooxygenase 2) Leucine EC 2-7-1 (protein kinase C alpha) 150-13-0 (4-Aminobenzoic Acid) Survival Rate ph [Physiology]
Last updated on Wednesday, March 04, 2020